Literature DB >> 30929007

When, where, and how to target vascular inflammation in the post-CANTOS era?

Pasquale Maffia1,2,3, Tomasz J Guzik1,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30929007      PMCID： PMC6685316          DOI： 10.1093/eurheartj/ehz133

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  19 in total

1.  Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice.

Authors:  Matthew R Alexander; Christopher W Moehle; Jason L Johnson; Zhengyu Yang; Jae K Lee; Christopher L Jackson; Gary K Owens
Journal:  J Clin Invest       Date:  2011-12-27       Impact factor: 14.808

2.  Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size.

Authors:  Cecilia M Devlin; George Kuriakose; Emmet Hirsch; Ira Tabas
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

3.  Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice.

Authors:  Vinay Bhaskar; Johnny Yin; Amer M Mirza; Dan Phan; Sandra Vanegas; Hassan Issafras; Kristen Michelson; John J Hunter; Seema S Kantak
Journal:  Atherosclerosis       Date:  2011-02-24       Impact factor: 5.162

Review 4.  Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.

Authors:  Charles A Dinarello
Journal:  Blood       Date:  2011-02-08       Impact factor: 22.113

5.  Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice.

Authors:  Hirokazu Kirii; Tamikazu Niwa; Yasuhiro Yamada; Hisayasu Wada; Kuniaki Saito; Yoichiro Iwakura; Masahide Asano; Hisataka Moriwaki; Mitsuru Seishima
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-27       Impact factor: 8.311

6.  Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice.

Authors:  Kikuo Isoda; Shojiro Sawada; Norio Ishigami; Taizo Matsuki; Koji Miyazaki; Masatoshi Kusuhara; Yoichiro Iwakura; Fumitaka Ohsuzu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-04-01       Impact factor: 8.311

7.  Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis.

Authors:  Stefan Freigang; Franziska Ampenberger; Adrienne Weiss; Thirumala-Devi Kanneganti; Yoichiro Iwakura; Martin Hersberger; Manfred Kopf
Journal:  Nat Immunol       Date:  2013-09-01       Impact factor: 25.606

8.  Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome.

Authors:  P Menu; M Pellegrin; J-F Aubert; K Bouzourene; A Tardivel; L Mazzolai; J Tschopp
Journal:  Cell Death Dis       Date:  2011-03-31       Impact factor: 8.469

Review 9.  Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?

Authors:  Paul Welsh; Gianluca Grassia; Shani Botha; Naveed Sattar; Pasquale Maffia
Journal:  Br J Pharmacol       Date:  2017-06-10       Impact factor: 8.739

10.  Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis.

Authors: 
Journal:  Lancet Diabetes Endocrinol       Date:  2015-02-26       Impact factor: 32.069
View more
  4 in total

Review 1.  COVID-19 - Toward a comprehensive understanding of the disease.

Authors:  Maciej M Kowalik; Piotr Trzonkowski; Magdalena Łasińska-Kowara; Andrzej Mital; Tomasz Smiatacz; Miłosz Jaguszewski
Journal:  Cardiol J       Date:  2020-05-07       Impact factor: 2.737

2.  COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.

Authors:  Tomasz J Guzik; Saidi A Mohiddin; Anthony Dimarco; Vimal Patel; Kostas Savvatis; Federica M Marelli-Berg; Meena S Madhur; Maciej Tomaszewski; Pasquale Maffia; Fulvio D'Acquisto; Stuart A Nicklin; Ali J Marian; Ryszard Nosalski; Eleanor C Murray; Bartlomiej Guzik; Colin Berry; Rhian M Touyz; Reinhold Kreutz; Dao Wen Wang; David Bhella; Orlando Sagliocco; Filippo Crea; Emma C Thomson; Iain B McInnes
Journal:  Cardiovasc Res       Date:  2020-08-01       Impact factor: 10.787

Review 3.  The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Authors:  Simon D Harding; Elena Faccenda; Christopher Southan; Adam J Pawson; Pasquale Maffia; Stephen P H Alexander; Anthony P Davenport; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Immunology       Date:  2020-03-02       Impact factor: 7.215

Review 4.  Cytokines at the Interplay Between Asthma and Atherosclerosis?

Authors:  Danila Gurgone; Lucy McShane; Charles McSharry; Tomasz J Guzik; Pasquale Maffia
Journal:  Front Pharmacol       Date:  2020-03-04       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.